Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of Dose Dense Chemotherapy With Lipegfilgrastim Support

NCT02527317 is registered in ClinicalTrials.gov with Beaumont Hospital as lead sponsor.

NCT NCT02527317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02527317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of Dose Dense Chemotherapy With Lipegfilgrastim Support
Lead sponsor
Beaumont Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2015
Completion date
February 28, 2018
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer